4.7 Article

Induced Pluripotent Mesenchymal Stromal Cell Clones Retain Donor-derived Differences in DNA Methylation Profiles

期刊

MOLECULAR THERAPY
卷 21, 期 1, 页码 240-250

出版社

CELL PRESS
DOI: 10.1038/mt.2012.207

关键词

-

资金

  1. excellence initiative of the German federal government of the Faculty of Medicine, RWTH Aachen
  2. excellence initiative of the German state government of the Faculty of Medicine, RWTH Aachen
  3. state North-Rhine Westphalia within the BioNRW2 project StemCellFactory
  4. Stem Cell Network of North-Rhine Westphalia
  5. Koln Fortune Program
  6. German Research Foundation DFG [SPP1356]
  7. Federal Ministry for Education and Research
  8. Else-Kroner Fresenius Stiftung

向作者/读者索取更多资源

Reprogramming of somatic cells into induced - pluripotent stem cells (iPSCs) is an epigenetic phenomenon. It has been suggested that iPSC retain some tissue-specific memory whereas little is known about interindividual epigenetic variation. We have reprogrammed mesenchymal stromal cells from human bone marrow (iP-MSC) and compared their DNA methylation profiles with initial MSC and embryonic stem cells (ESCs) using high-density DNA methylation arrays covering more than 450,000 CpG sites. Overall, DNA methylation patterns of iP-MSC and ESC were similar whereas some CpG sites revealed highly significant differences, which were not related to parental MSC. Furthermore, hypermethylation in iP-MSC versus ESC occurred preferentially outside of CpG islands and was enriched in genes involved in epidermal differentiation indicating that these differences are not due to random de novo methylation. Subsequently, we searched for CpG sites with donor-specific variation. These epigenetic finger-prints were highly enriched in non-promoter regions and outside of CpG islands-and they were maintained upon reprogramming. In conclusion, iP-MSC clones revealed relatively little intraindividual variation but they maintained donor-derived epigenetic differences. In the absence of isogenic controls, it would therefore be more appropriate to compare iPSC from different donors rather than a high number of different clones from the same patient. Received 30 January 2012; accepted 5 September 2012; advance online publication 2 October 2012. doi:10.1038/mt.2012.207

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据